Radiotheraphy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology

• 

  Año 2004, Vol. 73, Número 2

  • Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress

    Diana Mary Tait

    págs. 115-117

    

  • The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway

    Jean-Louis Lefaix, Sylvie Delanian

    págs. 119-131

    

  • Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer

    Judith Earl, Julie MacLaren, Lone Gothard, Mary Woods, Peter Mortimer, Emma Hall, Clare Peckitt, Paul Cornes, John Yarnold, John Peacock

    págs. 133-139

    

  • Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?

    Michael Lefcoe, George B. Rodrigues, Rashid Dar, Ed. Brecevic, Robert Ash, Anna Tomiak, Richard Inculet, Pauline Truong, Walter Kocha, Edward Yu, Ian Craig, Richard Malthaner, Larry Stitt, Gregory M.M. Videtic, Mark Vincent

    págs. 141-148

    

  • The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer

    Sarah Swift, Keith Harris, Emma Thomas, David Sebag Montefiore, Adrian Crellin

    págs. 149-151

    

  • Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial

    Maureen Macmillan, Leslie Samuel, Karen MacKinnon, Nancy Bell, Sheila MacBride, Mary Wells, Alastair Munro, Gillian Raab, Hugh MacDougall

    págs. 153-162

    

  • Radiotherapy for nasopharyngeal carcinoma¿transition from two-dimensional to three-dimensional methods

    Anthony T.C. Chan, Peter M.L. Teo, Brigette B.Y. Ma

    págs. 163-172

    

  • Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer

    B. Pokrajac, J. Widder, R. Pötter, E. Selzer, R. Schmid, W. Dobrowsky

    págs. 173-177

    

  • Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: A multicenter, randomized, two-arm, open-label trial

    Lak Sookpreedee, Supamitr Trithratipvikul, Imjai Chitapanarux, Chonlakiet Khorprasert, Prasert Lertsanguansinchai, Somphob Sangkittipaiboon, Yongyut Kongthanarat, Ladawan Narkwong, Supatra Sangruchi, Pramook Phromratanapongse, Pichai Ngampanprasert, Poonkiat Rungpoka, Thanatip Tantivatana, Vicharn Lorvidhaya, Sirisak Puribhat, Vutisiri Veerasarn, Bannakij Lojanapiwat, Apichart Panichevaluk, Sathit Ruangdilokrat, Chanawat Tesavibul

    págs. 179-185

    

  • Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma

    S. Muschitz, C. Haie-Meder, Renaud de Crevoisier, C. Petit, P. Morice, P. Duvillard, E. Briot, P. Petrow

    págs. 187-194

    

  • High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma

    Sandra M. de Canha, Rob Glynne Jones, Linda Bryant, Peter J. Hoskin, Peter Bownes

    págs. 195-198

    

  • Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397)

    Edwin G.A. Aird, A. Margaret Bidmead, David P. Dearnaley, W.Philip.M. Mayles, Sue E. Griffiths, Richard J. Stephens, A.Rollo Moore, A.P. Jim Warrington

    págs. 199-207

    

  • Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter

    Joos V. Lebesque, Ben J. Mijnheer, Eugène M.F. Damen, Marco Schwarz

    págs. 209-218

    

  • High dose three-dimensional conformal boost (3DCB) using an orthogonal diagnostic X-ray set-up for patients with gynecological malignancy: a new application of real-time tumor-tracking system

    Hiroki Shirato, Hiroshi Taguchi, Kazuo Miyasaka, Takayuki Hashimoto, Hidemichi Watari, Noriaki Sakuragi, Daichi Uchida, Seiko Nishioka, Ritsu Yamamoto, Takeshi Nishioka, Akio Yonesaka

    págs. 219-222

    

  • Intensity modulated radiation therapy with electrons using algorithm based energy/range selection methods

    Uwe Oelfke, Mikael Karlsson, Björn Zackrisson, Xiangkui Mu, Lennart Olofsson, Simeon Nill

    págs. 223-231

    

  • Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation

    Madhur K. Garg, John DelRowe, Giridhar R. Gorla, Wainwright Jaggernauth, Jonathan J. Beitler, Ravindra Yaparpalvi, Anand K. Sharma, Paul Weiss

    págs. 233-236

    

  • Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: A report of the REACT working group of ESTRO

    Katalin Hideghety, Isabel M. Grillo, Bernard Dubray, Michele I. Saunders, John LeVay, Germaine Heeren, Susan Davidson, Rolf-Peter Muller, Stanley Dische, Vito Vitale, Jane Maher, Andrew Kramar, Özlem Uruk Ataman, Christine Haie-Meder, Carlos A. Reguerio, Ingela Turesson, Michela Marcenaro, Ann Barrett, Paul Van Houtte, Danielle De Haas-Kock

    págs. 237-249

    

  • Re: New radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Sterotactic radiotherapy? Intensity modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy? Or nothing at all? [Radiother

    Eugene Wong, Glenn Bauman

    págs. 251-252

    

  • Re: Vikram, B., The PSA conundrum. Radiother Oncol, 2004. 71(1): p. 1¿2

    Padraig Warde, Kirsty Wiltshire, Robert G. Bristow, Mary Gospodarowicz

    págs. 252-254

    

  • Letter to the Editor

    Bhadrasain Vikram

    págs. 254-255

    

  • Important ESTRO dates

    pág. 257

    

  • Calendar of Events

    págs. 258-259